U.S. Life Sciences Stock News

Recent performance snapshot Nabors Industries (NBR) has seen mixed share-price moves recently, with the stock down about 5.1% in the latest session, roughly flat over the past month, yet higher over the past 3 months and year to date. See our latest analysis for Nabors Industries. For context, the recent 5.1% one day share price decline comes after a strong run, with the share price up 21.85% over 90 days and a year to date share price return of 73.16%, while the 1 year total shareholder...

Airbnb CEO Brian Chesky has launched a new AI lab focused on building advanced artificial intelligence models and user interfaces. The initiative aims to go beyond traditional chatbots and signals an expansion of Airbnb's ambitions outside its core accommodation platform. The move represents a material shift in how the company may use technology to shape its long term product roadmap. Airbnb, traded as NasdaqGS:ABNB, is entering this AI push with a mixed recent share performance. The stock...

Regulatory milestone draws attention to MoonLake Immunotherapeutics stock MoonLake Immunotherapeutics (MLTX) recently reported encouraging outcomes from its final pre application discussions with the FDA for sonelokimab, a key regulatory milestone that appears to have sharpened investor focus on the stock. See our latest analysis for MoonLake Immunotherapeutics. The latest FDA progress comes after a choppy period for the stock, with the 1 year total shareholder return down 61.82% even as the...

Recent share performance puts Magnolia Oil & Gas (MGY) in focus Recent moves in Magnolia Oil & Gas (MGY) share price are drawing attention, with the stock up about 24% over the past year but down around 4% over the past month and 6% in the past 3 months. See our latest analysis for Magnolia Oil & Gas. With the share price at $27.51, Magnolia Oil & Gas has pulled back over the past quarter, with a 90 day share price return showing a 5.85% decline, even as its 1 year total shareholder return of...

In late May 2026, The J. M. Smucker Company took part in the Gartner Finance Symposium/Xpo, where Lead Independent Director Jonathan E. Johnson presented insights on the company’s financial and governance priorities at National Harbor, Maryland. At the same time, research highlighting rising input costs and potential earnings pressure for packaged food producers has sharpened investor focus on Smucker’s cost management and margin resilience. We’ll now examine how concerns about rising input...

Arrowhead Pharmaceuticals (ARWR) is back in focus after new clinical and regulatory updates around its siRNA platform, including fresh data for plozasiran and ARO-INHBE that were shared at recent European medical meetings. See our latest analysis for Arrowhead Pharmaceuticals. Despite the clinical momentum around plozasiran and ARO-INHBE, short term trading has cooled, with the 7 day share price return down 6.2% and the 30 day share price return down 7.6%, even as the 1 year total shareholder...

Recent performance and context for Tenet Healthcare stock Tenet Healthcare (THC) has drawn fresh attention after a mixed stretch for the stock, with recent share performance contrasting with longer term returns and prompting investors to reassess how the business fundamentals line up with current pricing. See our latest analysis for Tenet Healthcare. Recent trading has been choppy, with the share price down 16.68% on a 30 day basis and 31.61% over 90 days. However, the 3 year total...

Custom Truck One Source (CTOS) is back on investors’ radar after two key developments: a cooperative purchasing contract award from Sourcewell and stronger than expected quarterly results paired with a raised full year outlook. See our latest analysis for Custom Truck One Source. Despite the recent 1-day share price return slipping 3.2% to close at US$9.68, Custom Truck One Source has built strong momentum, with a 90-day share price return of 51.01% and a 1-year total shareholder return of...

Satellogic (SATL) has drawn fresh attention after appointing retired U.S. Army Lieutenant General Michael E. Williamson to its Board as an independent director, highlighting the company’s focus on defense oriented Earth observation services. See our latest analysis for Satellogic. The recent appointment, the more than $18 million defense contract, and investor outreach around the Merlin constellation come as Satellogic’s share price shows mixed momentum, with a sharp 1 day decline but a very...

Archrock (AROC) is back in focus after first quarter 2026 results came in below earnings and revenue estimates, with flat adjusted earnings year over year and guidance for full year adjusted EBITDA reaffirmed. See our latest analysis for Archrock. At a share price of $34.20, Archrock has seen its short term momentum cool, with the 30 day share price return down 12.53% after a softer earnings print. However, the year to date share price return of 28.43% and a very large 5 year total...

White Mountains Insurance Group recently released its 2026 Annual Investor Presentation, outlining past 2025 results, strong book value per share growth, and key portfolio moves such as the Bamboo sale and HG Global refinancing. A distinctive takeaway is the combination of record capital deployment, substantial undeployed capital, and no parent financial leverage, underscoring the group’s financial flexibility and capacity to pursue new opportunities. Next, we’ll examine how this record...

Why Solidion's Battery Announcements Matter for Stock Watchers Solidion Technology (STI) has put battery chemistry squarely in focus, with fresh announcements on lithium metal anode protection and extreme climate batteries aimed at space, AI data centers, and demanding terrestrial uses. For investors tracking Solidion stock, these product updates highlight how the company is pitching its technology around three long standing hurdles in advanced lithium batteries, along with temperature...

If you are wondering whether BlackSky Technology's current share price lines up with its underlying worth, this breakdown will help you connect the recent moves in the stock with its valuation. The stock closed at US$34.76, after declining 28.3% over the past week and 14.2% over the past month, yet it is still up 67.0% year to date and 169.5% over the past year, with a 152.6% return over three years and a 56.5% decline over five years. Recent coverage has focused on BlackSky Technology's...

Wondering if International Seaways at around US$81 a share still offers value, or if most of the opportunity is already reflected in the price. The stock has been volatile recently, with a 5.0% gain over the past week, a 5.5% decline over the past month, and very strong returns of 72.5% year to date and 135.1% over the last year. Those moves sit against a longer track record where the 3 year return is 206.2% and the 5 year return is a very large gain. This suggests the stock has already...

Lennox International (NYSE:LII) received a global GOOD DESIGN® Award for its SL22KLV Cold Climate Heat Pump. The award recognizes the product's focus on energy efficient performance in challenging cold weather conditions. This recognition highlights the company's role in developing HVAC solutions for extreme environments. Lennox International, traded on the NYSE under ticker LII, focuses on heating, ventilation, air conditioning and refrigeration products for residential and commercial...

Gibraltar Industries recently announced that its CEO Bill Bosway and CFO Joe Lovechio met with investors at the Wells Fargo 16th Industrials & Materials Conference on June 10, where they discussed the company’s residential, agtech, and infrastructure businesses. A separate analyst report highlighted Gibraltar’s acquisition of OmniMax as a key driver of recent revenue growth and upgraded the company to a Strong Buy based on perceived valuation support and expected synergies. Next, we’ll...

Recent analyst actions around PACCAR (PCAR), along with year over year growth in quarterly revenue and net profit, have put the truck maker back in focus as investors look ahead to the next earnings report. See our latest analysis for PACCAR. The recent run up in PACCAR’s stock has cooled, with the share price down 1.17% over the last day but still ahead year to date. A 1 year total shareholder return of 27.95% and 3 year total shareholder return of 69.60% suggest investors who stayed the...

Samsara (IOT) opened its Q1 2027 report with revenue of US$478.8 million and basic EPS of US$0.08, setting a clear marker for how the business is translating its top line into profit. The company reported revenue of US$366.9 million in Q1 2026 and US$478.8 million in Q1 2027, while basic EPS moved from a loss of US$0.04 in Q1 2026 to a profit of US$0.08 in the latest quarter. This puts margins and profitability firmly in focus for investors watching how this earnings profile develops. See our...

Wondering if CSX at around US$46.99 is still good value, or if most of the upside is already reflected in the price? This article walks through what the current valuation signals actually say. CSX's share price is at US$46.99, with returns of 3.8% over the last 7 days, 3.0% over 30 days, 29.6% year to date and 47.9% over 1 year. The 3 year and 5 year returns are 51.8% and 55.2% respectively. Recent news has centered on CSX's role in US transportation infrastructure and how rail capacity,...

If you are wondering whether Visteon stock still offers value after a strong run, the key is to separate price excitement from underlying worth. The stock closed at US$117.46, with returns of 3.3% over the last 30 days and 21.2% year to date, while the 1 year return sits at 42.4% and the 3 and 5 year periods show declines of 20.3% and 6.4% respectively. Recent coverage of Visteon has focused on its role within the auto components sector and how the stock fits into broader market...

Recent share performance and business context Stoke Therapeutics (STOK) has given investors a mixed ride recently, with the stock down about 10% over the past month and 15% over the past 3 months, despite a much stronger total return over the past year. At a recent close of US$30.01 and a market value of about US$1.88b, the company sits squarely in mid cap territory, backed by a focused pipeline built around its TANGO platform for treating severe genetic diseases. See our latest analysis for...

Wealthfront (WLTH) has drawn fresh attention after recent trading, with the stock closing at US$9.85 and showing mixed performance, down over the past month yet higher over the past 3 months. See our latest analysis for Wealthfront. The recent 1 day share price return of down 14.35% and 7 day share price return of down 19.39% contrast with a 90 day share price return of 16.02%. This suggests fading short term momentum after a stronger quarter. If that shift in sentiment has you reassessing...

Solventum Corporation recently reported Q1 2026 results with 2.1% organic sales growth, 11% adjusted EPS growth, progress on its ERP migration, and the launch of a US$1.00 billion share repurchase program, while also presenting at the Jefferies Global Healthcare Conference in New York. Despite investor concerns about AI-related disruption in its Health Information Systems unit, Solventum is generating positive organic growth and free cash flow across all segments, prompting some shareholders...

Ziff Davis reported a past Q1 2026 earnings miss, with a 1.9% year-on-year revenue decline driven by weakness in its Tech & Shopping segment, and management outlined plans to divest the Connectivity business, pursue other asset sales, and continue sizeable share repurchases. At the same time, Ziff Davis is leaning into AI-enabled product development and efficiency improvements, aiming to reshape its portfolio mix and cost base while monetizing non-core assets such as the Connectivity...